[CLDX] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
03-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- 4.66%
YoY- -31.27%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 1,101 592 416 620 980 97 2,414 -40.72%
PBT -28,082 -28,274 -29,903 -22,062 -23,140 -19,016 -17,332 37.90%
Tax -2,260 -275 -1,586 -137 -142 -161 -379 228.47%
NP -28,082 -28,274 -29,903 -22,062 -23,140 -19,016 -17,332 37.90%
Tax Rate - - - - - - - -
Total Cost 29,183 28,866 30,319 22,682 24,120 19,113 19,746 29.71%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin -2,550.59 -4,776.01 -7,188.22 -3,558.39 -2,361.22 -19,604.12 -717.98 132.63%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS -4.71 -4.75 -5.02 -3.71 -4.28 -3.53 -3.51 21.63%
EPS Diluted -4.71 -4.75 -5.02 -3.71 -4.28 -3.53 -3.51 21.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.